Connective tissue growth factor (CCN2/CTGF) is not normally expressed in gingival fibroblasts, but is induced by the potent profibrotic cytokine TGFβ and is overexpressed in gingival fibrosis. Since CCN2 is a marker and mediator of fibrosis, targeting CCN2 expression in gingival fibroblasts may provide new insights into the future development of novel therapeutic opportunities to treat oral fibrosis. Herein we used real-time polymerase chain-reaction, Western blot, and indirect immunofluorescence analysis to evaluate whether SB-431542, a specific pharmacological inhibitor of TGFβ type I receptor (ALK5), blocks the ability of TGFβ to induce CCN2 mRNA and protein expression in human gingival fibroblasts. Our results indicate that CCN2 mRNA and protein are induced by TGFβ in gingival fibroblasts in a SB-431542-sensitive fashion. These results suggest that blocking ALK5 may be useful in blocking the profibrotic effects of TGFβ in gingival fibroblasts.
BlackSAJrTrackmanPC (2008). Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression. J Biol Chem283:10835-10847.
2.
BlackSAJrPalamakumburaAHStanMTrackmanPC (2007). Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase. J Biol Chem282:15416-15429.
3.
BlomIEGoldschmedingRLeaskA (2002). Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?Matrix Biol21:473-482.
4.
ChenYSegariniPRaoufiFBradhamDLeaskA (2001). Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Exp Cell Res271:109-117.
5.
ChenYBlomIESaSGoldschmedingRAbrahamDJLeaskA (2002). CTGF expression in mesangial cells: involvement of SMADs, MAP kinase and PKC. Kidney Int62:1149-1159.
6.
HallEE (1997). Prevention and treatment considerations in patients with drug-induced gingival enlargement. Curr Opin Periodontol4:59-63.
7.
GrayMRMalmquistJASullivanMBleaMCastellotJJJr (2007). CCN5 expression in mammals. II. Adult rodent tissues. J Cell Commun Signal1:145-158.
8.
GrotendorstGROkochiHHayashiN (1996). A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ7:469-480.
9.
HeathJKGowenMMeikleMCReynoldsJJ (1982). Human gingival tissues in culture synthesize three metalloproteinases and a metalloproteinase inhibitor. J Periodontal Res17:183-190.
HolmesAAbrahamDJSaSShiwenXBlackCMLeaskA (2001). CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem276:10594-10601.
12.
HongHHUzelMIDuanCSheffMCTrackmanPC (1999). Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva. Lab Invest79:1655-1667.
13.
ItoYAtenJBendeRJOemarBSRabelinkTJWeeningJJ. (1998). Expression of connective tissue growth factor in human renal fibrosis. Kidney Int53:853-861.
14.
KantarciABlackSAXydasCEMurawelPUchidaYYucekal-TuncerB. (2006). Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis. J Pathol210:59-66.
15.
KennedyLLiuSShi-WenXChenYEastwoodMCarterDE. (2007). CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res313:952-964.
16.
LawrenciaCCharrierAHuangGBrigstockDR (2009). Ethanol-mediated expression of connective tissue growth factor (CCN2) in mouse pancreatic stellate cells. Growth Factors27:91-99.
17.
LazarNManaraCNavarroSBleauAMLlombart-BoschAScotlandiK. (2007). Domain-specific CCN3 antibodies as unique tools for structural and functional studies. J Cell Commun Signal1:91-102.
18.
LeaskA (2004). Transcriptional profiling of the scleroderma fibroblast reveals a role for CTGF in fibrosis. Keio J Med53:74-77.
19.
LeaskAAbrahamDJ (2004). The control of TGFβ signaling in wound healing and fibrosis. FASEB J18:816-827.
20.
LeaskAAbrahamDJ (2006). All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci119(Pt 23):4803-4810.
21.
LeaskASaSHolmesAShiwenXBlackCMAbrahamDJ (2001). The control of CTGF (ccn2) gene expression in normal and scleroderma fibroblasts. Mol Pathol54:180-183.
22.
LeaskAHolmesABlackCMAbrahamDJ (2003). Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem278:13008-13015.
23.
LeaskAChenSPalaDBrigstockDR (2008). Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells. J Cell Commun Signal2:49-56.
PalaDKapoorMWoodsAKennedyLLiuSChenS. (2008). FAK/src suppresses early chondrogenesis: central role of CCN2. J Biol Chem283:9239-9247.
26.
ParadisVDargereDVidaudMDe GouvilleACHuetSMartinezV. (1999). Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology30:968-976.
27.
RicuperoDARishikofDCKuangPPPoliksCFGoldsteinRH (1999). Regulation of connective tissue growth factor expression by prostaglandin E(2). Am J Physiol277(6 Pt 1):L1165-L1171.
28.
Shi-wenXStantonLAKennedyLPalaDChenYHowatSL. (2006). CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem281:10715-10726.
29.
StrattonRRajkumarVPonticosMNicholsBShiwenXBlackCM. (2002). Prostacyclin derivatives prevent the fibrotic response to TGFβ by inhibiting the ras/MEK/ERK pathway. FASEB J16:1949-1951.
Van BeekJPKennedyLRockelJSBernierSMLeaskA (2006). The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther8:R36.
32.
XiaoRKanekuraTYoshidaNHigashiYYanKLFukushigeT. (2008). 9-Cis-retinoic acid exhibits antifibrotic activity via the induction of cyclooxygenase-2 expression and prostaglandin E2 production in scleroderma fibroblasts. Clin Exp Dermatol33:484-490.
33.
XiaoYQLiuKShenJFXuGTYeW (2009). SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol Vis Sci50:1698-1706.
